Background and Purpose-Increasing attention has been paid to associations between cognitive dysfunction and brain microbleeds (MBs). Because all previous studies have investigated patients with neurological disorders, we examined subjects without neurological disorder in order to clarify pathogenic relationships. Methods-A total of 518 consecutive adults without neurological disorder who had undergone health-screening tests of the brain were studied prospectively. Gradient-echo T2*-weighted MRI using a 1.5-T system was used to detect MBs. The Mini-Mental State Examination (MMSE) was administered to determine cognitive functions. MMSE scores Ͻ27 or Ͼ1.5 SDs below the age-related mean were regarded as subnormal. Results-MBs were found in 35 subjects (6.8%). MMSE score Ͻ27 was found in 25 subjects (4.8%), with MMSE score Ͼ1.5 SDs below the age-related mean in 34 subjects (6.6%). Univariate analysis showed presence and number of MBs, short duration of education, and severe white matter hyperintensities as significantly associated with subnormal scores. 
V ascular dementia is the most common cause of agerelated dementia and is preventable. Small-vessel disease (SVDs), particularly of an ischemic nature, is generally accepted as a major risk factor for vascular dementia. [1] [2] [3] Increasing attention has been paid to associations between cognitive dysfunction and brain microbleeds (MBs) on gradient-echo T2*-weighted MRI (GE-MRI). 4 MBs, which are characterized histologically by the presence of hemosiderin around small vessels, 5, 6 display several presentations, mainly as hypertensive arteriopathy or amyloid angiopathy. 5 Strong associations are considered to exist between MBs and SVDs (such as leukoaraiosis and a lacunar state), which can themselves cause ischemic or hemorrhagic cerebrovascular damage, due to shared risk factors such as chronic hypertension, [7] [8] [9] [10] [11] increasing age, 12 and ischemic 8, [13] [14] [15] and hemorrhagic stroke. 6,10,16 -19 MBs are often detected in demented individuals, such as patients with Alzheimer disease, 20 cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), 21, 22 subcortical vascular dementia, 23 or memory loss. 24 In patients with lobar intracranial hemorrhage, cognitive decline has been shown to be more severe in subjects with larger numbers of MBs at baseline. 18 A hospital-based study also showed an association between MBs and cognitive dysfunction. 25 If MBs are primarily involved in cognitive impairment, MBs may also be detected in certain subjects with no history of neurological disorder, but with cognitive impairment.
The present study, therefore, analyzed relationships between MBs and global cognitive function in a sample of independently living adults without neurological disorder.
Methods

Subjects
A total of 678 consecutive adults underwent health-screening tests of the brain in our center at their own expense between December 2005 and November 2007. The same system of health-screening tests for the brain was described in a previous study. 26 These individuals were considered as potential subjects for this study. To be included, subjects had to meet the following criteria: (1) age Ն30 years; (2) no disability in instrumental activities of daily living; (3) ability to independently make visits for current health-screening tests of the brain; and (4) voluntary provision of written informed consent. Exclusion criteria were: (1) inability to undergo cerebral MRI; (2) history of neurological disorder or brain injury; and (3) abnormality in neurological examination. All protocols were approved by the institutional review board. Of the initial 678 potential subjects, 112 individuals refused to enroll and 5 had a history of neurological disorder or brain injury. Among the remaining 561 subjects, 4 subjects displayed motion artifacts on MRI and data required for analysis were incomplete in 39 subjects (incomplete MRI, nϭ32; incomplete MMSE, nϭ4; incomplete laboratory data, nϭ3). As a result, we were able to prospectively study 518 subjects (251 men, 267 women; age, 33 to 85 years).
Baseline Assessment
We recorded age, gender, years of education, past history of ischemic heart diseases, family history of stroke, smoking status, and presence of hypertension, diabetes mellitus and hyperlipidemia as baseline clinical characteristics. Hypertension was defined as systolic blood pressure (SBP) Ͼ140 mm Hg and/or diastolic blood pressure Ͼ90 mm Hg or use of antihypertensive medication. Diabetes mellitus was defined as fasting serum glucose level Ն126 mg/dL, hemoglobin A1c levels Ն6.5% or use of antidiabetic medication. Hyperlipidemia was defined as fasting serum total cholesterol level Ն220 mg/dL and/or fasting serum triglyceride levels Ն200 mg/dL and/or use of antihyperlipidemic agents. Patients who were smokers at the time of analysis were classified as current smokers. Past history of ischemic heart disease, family history of stroke, and duration of education were obtained from each subject.
Clinical Assessment
All subjects were at first examined by a general physician. Subjects with suspected neurological deficits or abnormal findings on MRI subsequently underwent neurological examination by a certified neurosurgeon or neurologist.
Assessment of Cognitive Function
Global cognitive function was assessed using the Mini-Mental State Examination (MMSE). 27 We defined subnormal MMSE scores by 2 methods. First, according to the latest MMSE guideline, 28 total scores Ͻ27 were defined as subnormal. Second, MMSE scores Ͼ1.5 SDs below the mean for each given age were judged as subnormal. This second method was based on one of the diagnostic criteria used in previous studies of mild cognitive impairment. 29 
Magnetic Resonance Imaging
MRI was performed using a 1.5-T scanner (EXCELART Vantage, version 7.0; Toshiba Medical Systems). GE-MRI was performed in the axial plane with the following parameters: repetition time (TR), 735 ms; echo time (TE), 20 ms; flip angle (FA), 30°; section thickness, 7 mm; gap width, 1.4 mm; matrix, 224ϫ320; field of view (FOV) 220ϫ220 mm 2 . Conventional MRI such as axial T1-weighted imaging (T1WI; TR, 550 ms; TE, 15 ms), axial fluid-attenuated inversion recovery (FLAIR) imaging (TR, 10,000 ms; TI, 2500 ms; TE, 96 ms), and axial fast spin-echo T2-weighted imaging (T2WI; TR, 4000 ms; TE, 108 ms) was also obtained using the same section thickness and matrix.
MBs were defined on GE-MRI as rounded areas of signal loss, 2 to 10 mm in diameter. Two investigators (Y.Y., A.U.) who were blinded to subject data reviewed the number and location of MBs. Symmetrical hypointensities in the globus pallidum caused by calcification and flow void artifacts of pial vessels were carefully excluded. White matter hyperintensities (WMH), periventricular hyperintensities (PVH), and lacunae were independently reviewed by 2 of the authors (M.E., Y.N.) who were blinded to subject data. Severity of WMH or PVH on T2WI and FLAIR imaging was rated according to the Fazekas scale (WMH: grade 1, punctuate; grade 2, early confluence; and grade 3, confluent; and PVH: grade 1, caps or lining; grade 2, bands; and grade 3, irregular extension into the deep white matter). 30 Grades Ն2 in the Fazekas scale were regarded as severe WMH or PVH. Lacunae were defined as focal, sharply demarcated lesions Ͼ3 mm in diameter showing high intensity on T2WI and low intensity on T1WI.
Each value of inter-rater reliability for MRI findings, expressed as Cohen , was within the range of 0.60 to 0.75. Each value of intrarater reliability for MRI findings was determined from 50 randomly selected scans that were scored twice, again expressed as Cohen . Each value was within the range of 0.65 to 0.86.
Using a computer-assisted processing system (Image J version 1.38; National Institutes of Health) and the methods of Koga et al, 31 we calculated percentage brain value (%Brain) as an index of cerebral atrophy. Briefly, the area of cerebral parenchyma quantified on T2WI in 2 slices above the pineal body was divided by the area inside the skull at the same level. 31 
Statistics
Statistical analysis was performed using the Statistical Package for the Social Sciences version 11.0 software (SPSS). To compare baseline characteristics and MRI findings between 2 groups, the 2 test and Mann-Whitney U test were used as appropriate. Clinical variables with PϽ0.20 in univariate analysis, in addition to age and gender, were entered into multiple logistic regression analysis for the determination of significant, independent factors contributing to low MMSE score. Comparisons of total MMSE score and subscores between MB-positive and MB-negative groups were also performed. Values of PϽ0.05 were considered statistically significant.
Results
MBs were detected in the brain for 35 of 518 subjects (6.8%). Of these 35 subjects, 28 displayed only supratentorial MBs and 4 showed only infratentorial MBs, with 3 subjects exhibiting MBs in both areas. We detected 78 MBs in the cerebrum, 7 in the brain stem and 4 in the cerebellum. In the cerebrum, 19 MBs were located in the basal ganglia, 19 in the thalamus, and 40 in the cortex, subcortex or deep white matter, of which 15 (37.5%) were located in the frontal lobe, 6 (15%) in the parietal lobe, 9 (22.5%) in the temporal lobe, and 10 (25%) in the occipital lobe.
Mean MMSE score was 29.36Ϯ1.32 (range, 22 to 30). MMSE scores Ͻ27 were found in 25 subjects (4.8%; MMSE score 26, nϭ11; 25, nϭ6; 24, nϭ3; 23, nϭ4; and 22, nϭ1). MMSE scores Ͼ1.5 SD below the mean for each given age were found in 34 subjects (6.6%; Table 1 ). Differences in baseline characteristics and MRI findings between subnormal and normal MMSE score groups are shown in Table 2 . In both analyses of cognitive function, subnormal MMSE scores were significantly associated with shorter duration of education, presence and number of MBs, and presence of severe WMH (Table 2) . Because both presence and number of MBs were significantly associated with subnormal MMSE scores on univariate analysis, we then examined whether both factors were independently associated with subnormal MMSE scores. Logistic regression analysis was adjusted for age, male gender, duration of education, SBP and severe WMH. Because a strong correlation existed between SBP and diastolic BP (DBP; Spearman correlation coefficient (r), 0.75) and SBP displayed a lower probability value than DBP, SBP was used for multivariate analysis. As a result, both presence and number of MBs were significantly associated with subnormal MMSE scores ( Presence of lacunae, n (%) 62 (13) 4 (16) 0.616 61 (13) 5 (15) 0.722
Presence of MBs, n (%) 28 (6) 7 (28) Ͻ0.001 27 (6) 8 (24) Ͻ0.001
No. of MBs, median (IQR)
Presence of severe WMH, n (%) 60 (12) Differences in MMSE total score and subscores between MB-positive (nϭ35) and MB-negative groups (nϭ483) are shown in Table 4 . In unadjusted analysis, total MMSE score and "attention and calculation" score were lower in the MB-positive group than in the MB-negative group (Pϭ0.015 and Pϭ0.006, respectively). Adjustment for age, gender, duration of education, SBP and severe WMH did not affect the significant association between MB-positive result and low "attention and calculation" score (Pϭ0.017).
We also analyzed the relationship between MB locations (basal ganglia, thalamus, and cortex, subcortex or deep white matter) and MMSE score (Table 5 ). Relationships were analyzed both unadjusted and adjusted by gender, age, duration of education, SBP, and severe WMH. Adjusted analysis revealed that presence of MBs in basal ganglia was associated with reduced "attention and calculation" score (Pϭ0.014), whereas presence of thalamic MBs was independently associated with reduced total (Pϭ0.036) and "orientation" (Pϭ0.012) MMSE score. No significant differences in MMSE scores were seen between subjects with MBs in the cortex, subcortex or deep white matter and subjects without MBs in these areas.
Discussion
Presence of MBs is reportedly significantly associated with cognitive dysfunction. [23] [24] [25] However, subjects in these studies were patients with neurological disorders. We first studied the relationship between MBs and global cognitive function in adults without neurological disorder. All subjects enrolled in this study were living independently with no history of neurological disorder and displayed normal results on neurological examination. Both the presence and number of MBs were found to be significantly associated with subnormal MMSE scores in these subjects. That is, the effect of MBs on global cognitive function appears to be independent of neurological disorders and coexisting clinical risk factors for 5 The presence of MBs may thus imply much more severe disruption of the neural network between cortical and subcortical structures than ischemic SVDs. Although the number of subjects with MBs was small, at 35 (6.8%), the incidence of MBs in adults without neurological disorder was compatible with results from previous cohorts with no cerebrovascular disease (4.7 to 7.7%). 9, 12, 32 As for the location, in common with previous studies, MBs were frequently located in the basal ganglia as well as in the frontal, parieto-occipital and temporal lobes. Such characteristic topographical distributions would partially explain our subanalysis data of relationships between MMSE subscores and MB locations. Patients with Parkinson disease and dementia have been shown to display significantly poor performance on "attention and calculation" tasks in the MMSE. 33 The prominent attention deficit in these conditions is considered to result from severe dysfunction of cholinergic pathways in the frontal-subcortical circuits. 34, 35 Predominant occurrence of MBs in the frontal lobe and basal ganglia may thus cause executive dysfunction. 25 In addition, thalamic MBs were also frequently found and might also be involved in the development of cognitive dysfunction. The thalamus is considered part of a neuronal network integrally involved in cognitive function. 36 Previous neuroimaging studies on patients with CADASIL have shown associations between microstructural alterations in the thalamus and low MMSE score 37 and executive dysfunction. 38 Hypertension reportedly represents a risk factor for cognitive impairment, 39, 40 and some reports have shown that lowering blood pressure can reduce the incidence of cognitive impairments. 41, 42 MBs have been considered as one of the types of organ damage caused by chronic hypertension, 43 implying that control of hypertension can reduce both formation of MBs and cognitive dysfunction.
Because our subjects comprised adults who wished to receive health-screening tests of the brain at their own expense, possible selection bias may have existed toward individuals with a relatively high degree of financial affluence or concern for their own health. Such bias might have been influenced by educational background. In addition, we used the MMSE alone as a method to assess cognitive function. The MMSE reportedly offers relatively low sensitivity for the assessment of cognitive function in patients with SVD. 44 However, MMSE is used worldwide as a cognitive assessment tool, and we studied a relatively large sample of 518 subjects and assessed cognitive function using 2 methods to lessen the implication of bias.
In conclusion, this study offers the first evidence that MBs are significantly associated with global cognitive dysfunction in adults without neurological disorder, indicating that MBs should be regarded as one of the residual effects of SVD relevant to vascular dementia.
